FDA proposes heavier fines for fake drug business
The Food and Drug Administration (FDA) is set to impose much higher fines on manufacturers, sellers and importers of fake drugs. The proposed amendment to the Drug Act of BE 2510 is seeking to fine fakedrug manufacturers up to Bt5 million, and sellers and importers up to Bt2 million.
"Convicted offenders are also liable to a jail term," FDA deputy secretarygeneral Weerawan Taengkaew said yesterday. According to the Drug Act of BE 2510, fakedrug manufacturers are liable to up to life imprisonment and a maximum fine of Bt50,000, while sellers and importers are liable to a jail term of up to 20 years and a maximum fine of Bt10,000.
6 December 2007